Market Research Report
Computational Biology Market with COVID-19 Impact Analysis, By Application, By Service, By End-User and By Region - Size, Share& Forecast from 2021-2027
|Computational Biology Market with COVID-19 Impact Analysis, By Application, By Service, By End-User and By Region - Size, Share& Forecast from 2021-2027|
Published: February 1, 2022
AnalystView Market Insights
Content info: 336 Pages
Delivery time: 2-3 business days
In 2020, the global computational biology market was worth more than USD 3,600.5 million, expected to develop at a CAGR of 22.5% during the study period.
Computational biology, also known as bioinformatics, is an interdisciplinary branch of science that employs mathematics, statistics, and computer science to comprehend and model the structures and processes of life. It incorporates many aspects of biology, including genetics, evolution, cell biology, and biochemistry. On a large scale, the process employs computational techniques such as algorithms to represent and simulate biological systems as well as interpret experimental data. Computational biology also aids in the understanding of disease treatment and cellular function by generating a database of biological information from amino-acid sequences, nucleotides, and macromolecular structures.
The increasing number of clinical studies in the field of pharmacogenomics is primarily driving the global computational biology market. This has contributed to a better understanding of the patient population's diverse biological makeup, biological pathways, and the genomes that support them. As a result, computational biology solutions are in high demand, as they aid in reducing the overall time required for drug discovery and other scientific experiments. The procedure also facilitates the visualization of tools for simulating advanced drug-drug interactions. Furthermore, the increasing demand for computational biology in epi-genomics, proteomics, and meta-genomics to understand protein structures and interactions is propelling the market growth. Additionally, significant technological improvements in medication development and disease modeling, as well as increased spending by commercial and government organizations in research and development (R&D) activities, is expected to boost the market in the near future.
The emergence of a new virus, Covid-19, has wreaked devastation over the world, with high mortality, a high rate of transmission, and a dearth of clinically approved medicines and vaccinations. Computational biology could play an important role in better understanding the viral pathogenic mechanism and proposing novel therapeutic techniques in order to identify safe and effective therapeutic solutions to treat this infectious disease.
The global computational biology market is segmented on the basis of application, service, end-user, and regions.
The computational biology market is divided into five segments based on application: cellular and biological simulation, drug discovery and disease modeling, pre-clinical drug development, clinical trials, and human body simulation software. Cellular and biological simulation is subdivided further into computational genomics and proteomics, pharmacogenomics, and others. Target identification, target validation, lead discovery, and optimization are subsets of drug discovery and disease modeling. Pharmacokinetics and pharmacodynamics are two subsets of pre-clinical development. Clinical trials are further subdivided into phases I, II, and III.
Cellular and biological simulation is expected to maintain its market share of more than 34.0 percent by 2027. Computational cell modeling and biological simulation aid in the understanding of cells' biological and physiological functions. Increased unmet medical needs and growing demand for personalized medicine are expected to shape the segment's future growth. For example, HPE's (HPE) high-performance computing capabilities are used in personalized medicine to improve healthcare delivery and patient diagnosis. Dassault Systems organized the "Living Heart Project," which created a 3D simulated model of a human heart in this direction.
Drug discovery and disease modeling are expected to be the fastest-growing segments during the forecast period, owing to investments in novel drug development and an increase in clinical trial failures. The market for drug discovery and disease modeling is currently in a healthy growth phase in order to improve diagnosis and prognosis. Furthermore, due to rising drug demand globally, preclinical drug development is expected to register the second-highest CAGR during the forecast period.
The market is divided into two segments based on services: in-house and contract services. Contract services had the largest market share in 2018 and are expected to maintain that position throughout the forecast period. The segment is expected to account for more than 50.0 percent of the market by 2027, owing to the fact that contract services are less expensive than in-house services.
Biological computation Contract Research Organizations (CRO) help to streamline biomedical research around the world. These CROs improve computational capabilities and reduce waste in contract research organizations. Contract services are expected to thrive during the study period, thanks to recent advancements in cloud computing and other IT technologies.
The demand for comprehensive and predictive models of cellular pathways has aided the demand for technologies that can detect gene expression. The introduction of microarrays is a major trend that is shaping the contours of the computational biology market. Market participants in computational biology have been looking for ways to use these technologies to find better cancer biomarker targets. The increasing use of bioinformatics and multiscale biological modeling in cell modeling is another important trend that is broadening the application avenue in the computational biology market.
To improve their market position in the global computational industry, key players are now focusing on implementing strategies such as adopting new technology, product innovations, mergers and acquisitions, joint venture, alliances, and partnerships. For instance, Peptilogics announced the completion of Phase 1 clinical trial for PLG0206 (lead compound), a broad-spectrum anti-infective. It has received FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation for its initial focus on the treatment of prosthetic joint infections (PJI).
Key features of the study:
This proposed research study on the computational biology market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2021-2027), considering 2020 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for computational biology market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the computational biology market
Impact of COVID-19 on computational biology market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on computational biology market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the computational biology market, we have also included competitive landscape and key innovator analysis for the computational biology market The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the computational biology market
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global computational biology market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
THE GLOBAL COMPUTATIONAL BIOLOGY MARKET KEY PLAYERS
Chemical Computing Group Inc.
Nimbus Discovery Llc
Simulation Plus Inc
Rosa & Co. LLC
Insilico Biotechnology AG
THE GLOBAL COMPUTATIONAL BIOLOGY MARKET, BY APPLICATION
Cellular & Biological Simulation
Software & Services
Others (Transcriptomics/ Metabolomics)
Drug Discovery & Disease Modelling
Preclinical Drug Development
Human Body Simulation Software
THE GLOBAL COMPUTATIONAL BIOLOGY MARKET, BY SERVICE
THE GLOBAL COMPUTATIONAL BIOLOGY MARKET, BY END- USER
THE GLOBAL COMPUTATIONAL BIOLOGY MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
The Middle East and Africa
United Arab Emirates
Rest of MEA